Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Cirillo

Showing results (461-470 of 477) with videos related to

Pageof 48
Sort By:
JCI Insight|April 19, 2022
Longitudinal analysis of T cell receptor repertoires reveals shared patterns of antigen-specific response to SARS-CoV-2 infectionRachel M Gittelman, Enrico Lavezzo, Thomas M Snyder, et al.
American Journal of Respiratory and Critical Care Medicine|October 11, 2014
Risk assessment of tuberculosis in immunocompromised patients. A TBNET studyMartina Sester, Frank van Leth, Judith Bruchfeld, et al.
Wellcome Open Research|February 15, 2020
Antibiotic resistance prediction for <i>Mycobacterium tuberculosis</i> from genome sequence data with MykrobeMartin Hunt, Phelim Bradley, Simon Grandjean Lapierre, et al.
Open Forum Infectious Diseases|July 22, 2025
The Ethiopian Third National Tuberculosis Drug Resistance Survey Incorporating Whole Genome SequencingShewki Moga, Muluwork Getahun, Zemedu Mohammed, et al.
The European Respiratory Journal|April 3, 2012
European union standards for tuberculosis careG B Migliori, J P Zellweger, I Abubakar, et al.
The Lancet. Infectious Diseases|December 5, 2017
Xpert MTB/RIF Ultra for detection of Mycobacterium tuberculosis and rifampicin resistance: a prospective multicentre diagnostic accuracy studySusan E Dorman, Samuel G Schumacher, David Alland, et al.
The European Respiratory Journal|December 30, 2017
A standardised method for interpreting the association between mutations and phenotypic drug resistance in <i>Mycobacterium tuberculosis</i>Paolo Miotto, Belay Tessema, Elisa Tagliani, et al.
The Lancet. Infectious Diseases|March 8, 2025
Immunogenicity, safety, and efficacy of the vaccine H56:IC31 in reducing the rate of tuberculosis disease recurrence in HIV-negative adults successfully treated for drug-susceptible pulmonary tuberculosis: a double-blind, randomised, placebo-controlled, phase 2b trialÁlvaro H Borges, Marisa Russell, Dereck Tait, et al.
Clinical Genetics|March 16, 2017
Copy number variants analysis in a cohort of isolated and syndromic developmental delay/intellectual disability reveals novel genomic disorders, position effects and candidate disease genesE Di Gregorio, E Riberi, E F Belligni, et al.
High Blood Pressure & Cardiovascular Prevention : the Official Journal of the Italian Society of Hypertension|March 12, 2020
Hyperuricemia and Risk of Cardiovascular Outcomes: The Experience of the URRAH (Uric Acid Right for Heart Health) ProjectAlessandro Maloberti, C Giannattasio, M Bombelli, et al.
Pageof 48

Showing results (461-470 of 477) with videos related to

Sort By:
Pageof 48
JCI Insight|April 19, 2022
Longitudinal analysis of T cell receptor repertoires reveals shared patterns of antigen-specific response to SARS-CoV-2 infectionRachel M Gittelman, Enrico Lavezzo, Thomas M Snyder, et al.
American Journal of Respiratory and Critical Care Medicine|October 11, 2014
Risk assessment of tuberculosis in immunocompromised patients. A TBNET studyMartina Sester, Frank van Leth, Judith Bruchfeld, et al.
Wellcome Open Research|February 15, 2020
Antibiotic resistance prediction for <i>Mycobacterium tuberculosis</i> from genome sequence data with MykrobeMartin Hunt, Phelim Bradley, Simon Grandjean Lapierre, et al.
Open Forum Infectious Diseases|July 22, 2025
The Ethiopian Third National Tuberculosis Drug Resistance Survey Incorporating Whole Genome SequencingShewki Moga, Muluwork Getahun, Zemedu Mohammed, et al.
The European Respiratory Journal|April 3, 2012
European union standards for tuberculosis careG B Migliori, J P Zellweger, I Abubakar, et al.
The Lancet. Infectious Diseases|December 5, 2017
Xpert MTB/RIF Ultra for detection of Mycobacterium tuberculosis and rifampicin resistance: a prospective multicentre diagnostic accuracy studySusan E Dorman, Samuel G Schumacher, David Alland, et al.
The European Respiratory Journal|December 30, 2017
A standardised method for interpreting the association between mutations and phenotypic drug resistance in <i>Mycobacterium tuberculosis</i>Paolo Miotto, Belay Tessema, Elisa Tagliani, et al.
The Lancet. Infectious Diseases|March 8, 2025
Immunogenicity, safety, and efficacy of the vaccine H56:IC31 in reducing the rate of tuberculosis disease recurrence in HIV-negative adults successfully treated for drug-susceptible pulmonary tuberculosis: a double-blind, randomised, placebo-controlled, phase 2b trialÁlvaro H Borges, Marisa Russell, Dereck Tait, et al.
Clinical Genetics|March 16, 2017
Copy number variants analysis in a cohort of isolated and syndromic developmental delay/intellectual disability reveals novel genomic disorders, position effects and candidate disease genesE Di Gregorio, E Riberi, E F Belligni, et al.
High Blood Pressure & Cardiovascular Prevention : the Official Journal of the Italian Society of Hypertension|March 12, 2020
Hyperuricemia and Risk of Cardiovascular Outcomes: The Experience of the URRAH (Uric Acid Right for Heart Health) ProjectAlessandro Maloberti, C Giannattasio, M Bombelli, et al.
Pageof 48